SEC Info - Hemispherx Biopharma Inc - ‘8-K’ for 8/14/12

SEC Info℠

Home

Help

Please Sign In

Hemispherx Biopharma Inc – ‘8-K’ for 8/14/12 – EX-10.1

On: Wednesday, 8/15/12, at 4:09pm ET · For: 8/14/12 · Accession #: 1144204-12-46324 · File #: 1-13441

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/15/12  Hemispherx Biopharma Inc          8-K:1,9     8/14/12    3:39K                                    Vintage/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     14K 
 2: EX-10.1     Material Contract                                   HTML      9K 
 3: EX-10.2     Material Contract                                   HTML      9K

EX-10.1 — Material Contract

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 10.1

August 14, 2012

Dr. William A. Carter

Chairman and CEO

Hemispherx Biopharma, Inc.

JFK Boulevard

Suite 660

Philadelphia, Pa 19103

Re: Agreement Between Armada Health Care, LLC and Hemispherx Biopharma, Inc.

Dear Dr. Carter,

Armada Health Care would like to request an extension to the above mentioned contract through August 14, 2013 subject to the same terms and conditions currently in place.

Please sign this acceptance letter as acknowledgment of the extension and return to my attention via fax or e-mail. I can be reached at 973-564-8004 if you have any questions or concerns.

Regards,

/s/ *Ryan Oligino*
Ryan Oligino
Vice President
Armada Health Care
Phone: 973-564-8004
Fax: 973-564-8010

		Accepted:

		/s/ *William A. Carter*
		William A. Carter, M.D.
		Chief Executive Offer
		Hemispherx BioPharma, Inc
		August 14, 2012

Dates Referenced Herein

This ‘8-K’ Filing	Date	Other Filings

	8/14/13	None on these Dates
Filed on:	8/15/12
For Period End:	8/14/12
		List all Filings

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/19/24  AIM ImmunoTech Inc.               S-1                    6:628K                                   M2 Compliance LLC/FA
 4/01/24  AIM ImmunoTech Inc.               10-K       12/31/23   84:8.7M                                   M2 Compliance LLC/FA
 3/31/23  AIM ImmunoTech Inc.               10-K       12/31/22   87:8.7M                                   M2 Compliance LLC/FA
 8/15/22  AIM ImmunoTech Inc.               10-Q        6/30/22   72:6M                                     M2 Compliance LLC/FA
 5/13/22  AIM ImmunoTech Inc.               10-Q        3/31/22   68:5.6M                                   M2 Compliance LLC/FA
 3/31/22  AIM ImmunoTech Inc.               10-K       12/31/21   90:9.3M                                   M2 Compliance LLC/FA
 3/31/21  AIM ImmunoTech Inc.               10-K       12/31/20   94:7.6M                                   M2 Compliance LLC/FA

↑Top

Filing Submission 0001144204-12-046324 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)